These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27588466)

  • 1. Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model.
    Lin LT; Chang CY; Chang CH; Wang HE; Chiou SH; Liu RS; Lee TW; Lee YJ
    Oncotarget; 2016 Oct; 7(40):65782-65796. PubMed ID: 27588466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.
    Huang FY; Lee TW; Chang CH; Chen LC; Hsu WH; Chang CW; Lo JM
    Int J Nanomedicine; 2015; 10():463-73. PubMed ID: 25624760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated
    Lin BZ; Wan SY; Lin MY; Chang CH; Chen TW; Yang MH; Lee YJ
    Molecules; 2020 Aug; 25(16):. PubMed ID: 32784458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging and therapeutic efficacy of 188Re-(DXR)-liposome-BBN in AR42J pancreatic tumor-bearing mice.
    Chang YJ; Yu CY; Hsu CW; Lee WC; Chen SJ; Chang CH; Lee TW
    Oncol Rep; 2012 Nov; 28(5):1736-42. PubMed ID: 22922965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.
    Lin LT; Chang CH; Yu HL; Liu RS; Wang HE; Chiu SJ; Chen FD; Lee TW; Lee YJ
    J Nucl Med; 2014 Nov; 55(11):1864-70. PubMed ID: 25349220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External beam radiotherapy synergizes ¹⁸⁸Re-liposome against human esophageal cancer xenograft and modulates ¹⁸⁸Re-liposome pharmacokinetics.
    Chang CH; Liu SY; Chi CW; Yu HL; Chang TJ; Tsai TH; Lee TW; Chen YJ
    Int J Nanomedicine; 2015; 10():3641-9. PubMed ID: 26056445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice.
    Chen MH; Chang CH; Chang YJ; Chen LC; Yu CY; Wu YH; Lee WC; Yeh CH; Lin FH; Lee TW; Yang CS; Ting G
    Anticancer Res; 2010 Jan; 30(1):65-72. PubMed ID: 20150618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
    Hsu CW; Chang YJ; Chang CH; Chen LC; Lan KL; Ting G; Lee TW
    Cancer Biother Radiopharm; 2012 Oct; 27(8):481-9. PubMed ID: 23067100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
    Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C
    Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative 186Re-liposome radionuclide therapy in a head and neck squamous cell carcinoma xenograft positive surgical margin model.
    Wang SX; Bao A; Herrera SJ; Phillips WT; Goins B; Santoyo C; Miller FR; Otto RA
    Clin Cancer Res; 2008 Jun; 14(12):3975-83. PubMed ID: 18559620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
    Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
    Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model.
    Hsu WH; Liu SY; Chang YJ; Chang CH; Ting G; Lee TW
    Nucl Med Biol; 2014 Oct; 41(9):765-71. PubMed ID: 25027866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma.
    Lang L; Shay C; Zhao X; Xiong Y; Wang X; Teng Y
    J Hematol Oncol; 2019 Dec; 12(1):132. PubMed ID: 31805962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and biodistribution of 188Re-labeled folate conjugated human serum albumin magnetic cisplatin nanoparticles (188Re-folate-CDDP/HSA MNPs) in vivo.
    Tang QS; Chen DZ; Xue WQ; Xiang JY; Gong YC; Zhang L; Guo CQ
    Int J Nanomedicine; 2011; 6():3077-85. PubMed ID: 22163161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradionuclide therapy with 186Re-labeled liposomal doxorubicin in combination with radiofrequency ablation for effective treatment of head and neck cancer in a nude rat tumor xenograft model.
    Soundararajan A; Dodd GD; Bao A; Phillips WT; McManus LM; Prihoda TJ; Goins BA
    Radiology; 2011 Dec; 261(3):813-23. PubMed ID: 22025735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
    Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW
    Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases.
    El-Mabhouh A; Mercer JR
    Appl Radiat Isot; 2005 Apr; 62(4):541-9. PubMed ID: 15701408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-bMEDA-liposome in a C26 murine colon carcinoma solid tumor animal model.
    Chang YJ; Chang CH; Chang TJ; Yu CY; Chen LC; Jan ML; Luo TY; Lee TW; Ting G
    Anticancer Res; 2007; 27(4B):2217-25. PubMed ID: 17695506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
    Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
    Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.